Monitoring the brain metabolites of children with acute encephalopathy caused by the H1N1 virus responsible for the 2009 influenza pandemic: A quantitative in vivo 1H MR spectroscopy study

Magnetic Resonance Imaging

Volumn 30, Issue 10, 2012, Pages 1527-1533

  Tomiyasu, Moyoko ^a,b   Aida, Noriko ^a,b   Watanabe, Yoshihiro ^b   Mori, Kana ^a,b   Endo, Kazuo ^a,b   Kusakiri, Kouki ^b   Kershaw, Jeff ^c   Obata, Takayuki ^a,b   Osaka, Hitoshi ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Acute encephalopathy; Brain metabolite concentration; Influenza; MR Spectroscopy; Pediatric patient

Indexed keywords

CHOLINE; CREATINE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; TAURINE;

2009 H1N1 INFLUENZA; ACUTE BRAIN DISEASE; ADOLESCENT; AMINO ACID BRAIN LEVEL; ARTICLE; BASAL GANGLION; BRAIN METABOLITE; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONSCIOUSNESS DISORDER; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; INFANT; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SEMIOVAL CENTER; SUBCORTEX; VOXEL BASED MORPHOMETRY;

ADOLESCENT; BRAIN; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS, VIRAL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RETROSPECTIVE STUDIES;

INFLUENZA A VIRUS;

EID: 84868648221     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2012.05.007     Document Type: Article

References (20)

1. Mizuguchi M., Yamanouchi H., Ichiyama T., et al. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 2007, 115(Suppl 186):45-56.
2. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci. 1987, 508:333-348.
3. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993, 30:672-679.
4. Dobbing J., Sands J. Quantitative growth and development of human brain. Arch Dis Child 1973, 48:757-767.
5. Kreis R., Ernst T., Ross B.D. Development of human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993, 30:424-437.
6. Provencher S. LCModel & LCMgui user's manual 2010, Stephen Provencher Inc, Oakville, Ontario, Canada, http://s-provencher.com/pages/lcmodel.shtml.
7. Health, Labour and Welfare Ministry, Japan http://www.mhlw.go.jp/.
8. Govindaraju V., Young K., Maudsley A.A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000, 13:129-153.
9. Benarroch E.E. N-Acetylasportate and N-acetylaspartylglutamate: neurobiology and clinical significance. Neurology 2008, 70:1353-1357.
10. Takanashi J., Tada H., Terada H., et al. Excitotoxicity in acute encephalopathy with biphasic seizures and late reduced diffusion. Am J Neuroradiol. 2009, 30:132-135.
11. Meldrum B.S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000, 130:1007S-1015S.
12. Huxtable R.J. Physiological actions of taurine. Physiol Rev 1992, 72:101-163.
13. Redmond H.P., Stapleton P.P., Neary P., et al. Immunonutrition: the role of taurine. Nutrition 1998, 14:599-604.
14. Yao D., Kuwajima M., Kido H. Pathologic mechanisms of influenza encephalitis with an abnormal expression of inflammatory cytokines and accumulation of min-plasmin. J Med Invest 2003, 50:1-8.
15. Sharp J.S., Becker J.M., Hettich R.L. Analysis of protein solvent accessible surfaces by photochemical oxidation and mass spectrometry. Anal Chem 2004, 76:672-683.
16. Wu H., Jin Y., Wei J., et al. Mode of action of taurine as a neuroprotector. Brain Res 2005, 1038:123-131.
17. Shirayama Y., Obata T., Matsuzawa D., et al. Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study. NeuroImage 2010, 49:2783-2790.
18. Opstad K.S., Bell B.A., Griffiths J.R., et al. Taurine: a potential marker of apoptosis in gliomas. Br J Cancer 2009, 100:789-794.
19. Gruetter R., Ugurbil K., Seaquist E.R. Steady-state cerebral glucose concentrations and transport in the human brain. J Neurochem 1998, 70:397-408.
20. Pouwerls P.J.W., Brockmann K., Kruse B., et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999, 46:474-485.